[Elsevier] Iberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trial |
|
This post will be closed automatically in 2026-10-06 00:46
Reward40points
|
10
Theoretical design and exploration of novel quaternary chalcogenides Cu3MScSe4 (M = Zn, Cd, Hg) for photovoltaic applications
10
Assessment of neutron and gamma-ray shielding characteristics in ternary composites: Experimental analysis and Monte Carlo simulations
10
ZnO-enhanced borotellurite glasses: A comparative investigation of radiation shielding via experiment and simulation approaches
10
Block-branched poly(aryl piperidinium) anion exchange membrane for highly durable pure water electrolysis
10
Investigation on radiation interactions with some quenched alloys used in nuclear reactors
